165 results
424B3
INM
InMed Pharmaceuticals Inc.
27 Jun 24
Prospectus supplement
6:27pm
benefits, either cost, yield, speed, or all of the above, when pursuing specific types of cannabinoids, and filing a provisional patent application for same … ;
Plans regarding our next steps, options, and targeted benefits of our manufacturing technologies;
Our IntegraSyn- or BayMedica-derived products
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc.
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
and regulations for a reporting company.
REMUNERATION AND BENEFITS
Base Salary.
The Company will pay the Executive an annual salary of C$325,000, for full-time … and Governance Professionals of Canada;
Page 3 of 29
Other Benefits. The Company will facilitate the Executive’s enrolment in the Company’s insured benefits
424B3
bivswj0p2ng
13 Nov 23
Prospectus supplement
5:05pm
8-K
EX-4.1
xampzeun3h85156qsz4
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.3
jsi tqjqvx6vnx9
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.2
ygmp0z qden9wc30jc4
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.3
m77pzx0sa5gymrvu3cl
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.1
ek0r3xau1mbuxbj9e
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
424B3
ekt0m vvzf
15 Dec 22
Prospectus supplement
11:42am
8-K
EX-10.2
emtgol9pbuxszo 7vm
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
EX-10.1
2lx3d2jq1p5bfi1
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm